Early New Ischemic Lesions Located Outside the Initially Affected Vascular Territory Appear More Often in Stroke Patients with Elevated Glycated Hemoglobin (HbA1c)

Tim Bastian Braemswig, Christian H Nolte, Jochen B Fiebach, Tatiana Usnich, Tim Bastian Braemswig, Christian H Nolte, Jochen B Fiebach, Tatiana Usnich

Abstract

Background: Early new ischemic lesions are common in patients with an acute ischemic stroke. These new ischemic lesions may represent the natural course of the initial stroke or de novo events.

Objective: We hypothesized that early new ischemic lesions located outside the initially affected vascular territory would point at de novo events. Therefore, we differentiated new ischemic lesions located outside the initially affected vascular territory from those occurring only inside the initially affected vascular territory to identify risk factors that are associated with de novo events.

Methods: Stroke patients underwent three magnetic resonance imaging examinations (at 3-T): on admission, on the next day and 4-7 days after symptom onset (clinicaltrials.gov: NCT00715533). Diffusion-weighted imaging (DWI) lesions were delineated, coregistered, and then analyzed for new hyperintensities on follow-up examinations by raters blinded to clinical details. Patients were classified as having "new distant lesions" if new DWI lesions appeared outside or both outside and inside the initially affected vascular territory or "new local lesions" if they were only inside.

Results: 115 patients with early new DWI lesions constitute the study population. Sixteen patients (14%) had new distant lesions and 99 patients (86%) had new local lesions. In comparison between patients with new distant and new local lesions, patients with new distant lesions had significantly more often elevated glycated hemoglobin (HbA1c ≥ 6.5%; p = 0.022).

Conclusion: Our data indicate that patients with elevated HbA1c have an increased risk for new, de novo ischemic lesions in the acute phase after an ischemic stroke.

Keywords: diabetes mellitus; diffusion magnetic resonance imaging; glycosylated; hemoglobin A; magnetic resonance imaging; new ischemic lesions; stroke.

Figures

Figure 1
Figure 1
Diffusion-weighted imaging (DWI) of four patients with new DWI lesions. New distant lesions, appearing on day 2 (A) and day 5 (B). New local lesions appearing on day 2 (C) and day 5 (D).

References

    1. Kang D-W, Latour LL, Chalela JA, Dambrosia J, Warach S. Early ischemic lesion recurrence within a week after acute ischemic stroke. Ann Neurol (2003) 54:66–74.10.1002/ana.10592
    1. Nolte CH, Albach FN, Heuschmann PU, Brunecker P, Villringer K, Endres M, et al. Silent new DWI lesions within the first week after stroke. Cerebrovasc Dis (2012) 33:248–54.10.1159/000334665
    1. Usnich T, Albach FN, Brunecker P, Fiebach JB, Nolte CH. Incidence of new diffusion-weighted imaging lesions outside the area of initial hypoperfusion within 1 week after acute ischemic stroke. Stroke (2012) 43:2654–8.10.1161/STROKEAHA.112.655993
    1. Braemswig TB, Usnich T, Albach FN, Brunecker P, Grittner U, Scheitz JF, et al. Early new diffusion-weighted imaging lesions appear more often in stroke patients with a multiple territory lesion pattern. Stroke (2013) 44:2200–4.10.1161/STROKEAHA.111.000810
    1. Lee E-J, Kang D-W, Warach S. Silent new brain lesions: innocent bystander or guilty party? J Stroke (2016) 18:38–49.10.5853/jos.2015.01410
    1. Kang D-W, Han M-K, Kim H-J, Sohn H, Kim BJ, Kwon SU, et al. Silent new ischemic lesions after index stroke and the risk of future clinical recurrent stroke. Neurology (2016) 86:277–85.10.1212/WNL.0000000000002289
    1. Asdaghi N, Hameed B, Saini M, Jeerakathil T, Emery D, Butcher K. Acute perfusion and diffusion abnormalities predict early new MRI lesions 1 week after minor stroke and transient ischemic attack. Stroke (2011) 42:2191–5.10.1161/STROKEAHA.110.611376
    1. Tatu L, Moulin T, Vuillier F, Bogousslavsky J. Arterial territories of the human brain. Front Neurol Neurosci (2012) 30:99–110.10.1159/000333602
    1. Hotter B, Pittl S, Ebinger M, Oepen G, Jegzentis K, Kudo K, et al. Prospective study on the mismatch concept in acute stroke patients within the first 24 h after symptom onset – 1000Plus study. BMC Neurol (2009) 9:60.10.1186/1471-2377-9-60
    1. The International Expert Committee. International expert committee report on the role of the A1C assay in the diagnosis of diabetes. Diabetes Care (2009) 32:1327–34.10.2337/dc09-9033
    1. Adams HP, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke (1993) 24:35–41.10.1161/01.STR.24.1.35
    1. Berger K, Weltermann B, Kolominsky-Rabas P, Meves S, Heuschmann P, Böhner J, et al. Untersuchung zur Reliabilität von Schlaganfallskalen. Fortschritte Neurol Psychiatr (1999) 67:81–6.10.1055/s-2007-993985
    1. European Stroke Organisation (ESO) Executive Committee, ESO Writing Committee. Guidelines for management of ischaemic stroke and transient ischaemic attack 2008. Cerebrovasc Dis (2008) 25:457–507.10.1159/000131083
    1. Kamouchi M, Matsuki T, Hata J, Kuwashiro T, Ago T, Sambongi Y, et al. Prestroke glycemic control is associated with the functional outcome in acute ischemic stroke: the Fukuoka stroke registry. Stroke (2011) 42:2788–94.10.1161/STROKEAHA.111.617415
    1. Oh HG, Rhee E-J, Kim T-W, Lee KB, Park J-H, Yang K-I, et al. Higher glycated hemoglobin level is associated with increased risk for ischemic stroke in non-diabetic Korean male adults. Diabetes Metab J (2011) 35:551.10.4093/dmj.2011.35.5.551
    1. Selvin E, Coresh J, Shahar E, Zhang L, Steffes M, Sharrett AR. Glycaemia (haemoglobin A1c) and incident ischaemic stroke: the atherosclerosis risk in communities (ARIC) study. Lancet Neurol (2005) 4:821–6.10.1016/S1474-4422(05)70227-1
    1. Vazzana N, Ranalli P, Cuccurullo C, Davì G. Diabetes mellitus and thrombosis. Thromb Res (2012) 129:371–7.10.1016/j.thromres.2011.11.052
    1. Mohan KM, Wolfe CDA, Rudd AG, Heuschmann PU, Kolominsky-Rabas PL, Grieve AP. Risk and cumulative risk of stroke recurrence: a systematic review and meta-analysis. Stroke (2011) 42:1489–94.10.1161/STROKEAHA.110.602615

Source: PubMed

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe